Lucid Diagnostics Inc. (LUCD) Tops Q3 EPS by 1c

Lucid Diagnostics Inc. (NASDAQ: LUCD) reported Q3 EPS of ($0.10), $0.01 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $1.21 million versus the consensus estimate of $1.36 million.

For earnings history and earnings-related data on Lucid Diagnostics Inc. (LUCD) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• Tutor Perini prices $400M in senior notes to refinance debt
• KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook